A phase II study of stent therapy for malignant vena cava syndrome. (JIVROSG-0402) - Stent therapy for vena cava syndrome (JIVROSG-0402)

Japan Interventional Radiology in Oncology Study Group(JIVROSG)0 个研究点目标入组 28 人开始时间: 2005年8月7日最近更新: 2023年10月17日

适应症

试验速览

阶段: 2 期
状态: 已完成
发起方
入组人数: 28

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

Patients: age (median) 60.5y (29-91), male 16/female 12, SVC 16/ IVC 12 Technical success: 100% Angiographic success: 96.4% Clinical success: 71.4% (95% CI: 54.7-88.1%) Time-to-improvement (median): 1 day Adverse events (>=G3): 7.14

研究设计

研究类型: Interventional

入排标准

年龄范围: ot applicable 至 ot applicable（—）
性别: All

入选标准

未提供

排除标准

•1) Potential benefit for symptom relief by chemotherapy, radiotherapy, or surgery. 2) Intraluminal tumor thrombus resulting in stenosis of vena cava. 3) Floating thrombus distal to stenosis. 4) Stenoses both in superior and inferior vena cava. 5) Central venous pressure higher than 8cm H2O. 6) Deformity of cardiac cavity, cardiac tamponade or severe functional disorder oberved by electrocardiogram and ultrasound examination. 7) Stenosis existinf both in SVC and IVC. 8) Active inflammatory disease. 9) Acute active bleeding. 10) Pregnancy.

研究者

发起方

Japan Interventional Radiology in Oncology Study Group(JIVROSG)

相似试验

已完成

不适用

Evaluation of stent angioplasty as a therapeutic option in the treatment of arteriosclerotic lesions of the common femoral artery.I70.20

DRKS00024584niversitäts-Herzzentrum Bad Krozingen250

已完成

2 期

Phase II study of dedicated silicone stent placement on the carina between the bronchus to the right upper lobe and bronchus intermediusAirway stenotic diseases

JPRN-UMIN000001776agoya Medical Center10

已完成

不适用

Covered Stents in Treatment of Coronary Artery PerforationCoronary Artery Perforation

NCT04630314Medical University of Silesia119

已完成

3 期

Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)Coronary Disease

NCT00165035Cordis Corporation1,701

终止

不适用

Antares Coronary Stent System to Facilitate Side Branch InterventionsCoronary artery diseaseCardiovascular - Coronary heart disease

ACTRN12609000487213TriReme Medical, Inc.300